Esta página foi traduzida automaticamente e a precisão da tradução não é garantida. Por favor, consulte o versão em inglês para um texto fonte.

Questionnaire Study Concerning Artificial Intelligence

3 de fevereiro de 2022 atualizado por: Maastricht University Medical Center

Questionnaire Study Concerning Artificial Intelligence and Its Application in (Gastrointestinal) Healthcare - Patients' and Physicians' Perspectives

This study aims to investigate the knowledge, experience, and opinion on AI among gastroenterology (GI) patients, gastroenterologists, and GI-fellows, particularly concerning implementation and application of AI (in assisting clinicians) in healthcare. The secondary aims are to investigate (dis)advantages of AI use in healthcare and the availability of technical facilities and infrastructures within endoscopy to implement and apply AI in Dutch hospitals.

Visão geral do estudo

Status

Concluído

Condições

Problemas gastrointestinais

Intervenção / Tratamento

Outro: Questionnaire

Descrição detalhada

In recent years, important developments have been made in the field of artificial intelligence (AI). These developments have led to the large-scale application of AI in our everyday lives and AI-research within healthcare. A potentially promising application of AI lies in imaging analysis. For example, within gastroenterology this means the detection and classification of colorectal polyps and Barrett's neoplasia, disease severity scoring of inflammatory bowel diseases, and differentiating pancreatic cancer from chronic pancreatitis.

Despite the investments in AI-research, there is a lack in knowledge concerning patients' and physicians' perspectives on AI in healthcare. This prospective questionnaire study investigates these perspectives, obtaining data from both gastroenterology (GI) patients and GI-physicians within the Netherlands. The questionnaires focus on the knowledge, experience, and opinion of AI, particularly concerning the implementation of AI in (gastroenterology) healthcare. Furthermore, the current (endoscopic) infrastructure within Dutch hospitals will be investigated for its readnessy for AI.

Tipo de estudo

Observacional

Inscrição (Real)

457

Contactos e Locais

Esta seção fornece os detalhes de contato para aqueles que conduzem o estudo e informações sobre onde este estudo está sendo realizado.

Locais de estudo

Holanda
- Limburg
  - Maastricht, Limburg, Holanda, 6202AZ
    - Maastricht University Medical Center
- Noord-Brabant
  - Eindhoven, Noord-Brabant, Holanda, 5623 EJ
    - Catharina Ziekenhuis Eindhoven

Critérios de participação

Os pesquisadores procuram pessoas que se encaixem em uma determinada descrição, chamada de critérios de elegibilidade. Alguns exemplos desses critérios são a condição geral de saúde de uma pessoa ou tratamentos anteriores.

Critérios de elegibilidade

Idades elegíveis para estudo

18 anos e mais velhos (Adulto, Adulto mais velho)

Aceita Voluntários Saudáveis

Não

Gêneros Elegíveis para o Estudo

Tudo

Método de amostragem

Amostra Não Probabilística

População do estudo

Gastroenterology patients who will have an outpatient appointment for an endoscopic procedure in the context of the national bowel cancer screening program, because of gastrointestinal symptoms, or because of follow-up of previously diagnosed bowel diseases, in one of two Dutch hospitals between April 2020 and September 2020.

Gastroenterologists and gastroenterology fellows working in Dutch hospitals.

Descrição

Inclusion Criteria:

Gastrointestinal (GI) patients with an outpatient appointment in the gastroenterology department for an endoscopic procedure in the context of the Dutch national screening program, because of gastrointestinal symptoms, or because of follow-up of previously diagnosed bowel diseases (in one of the two participating hospitals);
Gastroenterologists working in Dutch hospitals;
Gastroenterology fellows working in Dutch hospitals;
Minimal age of 18 years old.

Exclusion Criteria:

No appropriate understanding of the Dutch language;
Not willing to sign informed consent;
Objection to participate in medical scientific research, reported in the medical file.

Plano de estudo

Esta seção fornece detalhes do plano de estudo, incluindo como o estudo é projetado e o que o estudo está medindo.

Como o estudo é projetado?

Detalhes do projeto

Número de grupos/coortes

Coortes e Intervenções

Grupo / Coorte	Intervenção / Tratamento
Gastroenterology patients Patient receiving an endoscopic procedure because of regular care will be considered eligible for inclusion. Patients receive an endoscopic procedure in the context of the Dutch national screening program, because of gastrointestinal symptoms, or because of follow-up of previously diagnosed bowel diseases. Patients will be asked to complete a questionnaire concerning AI. No intervention will be administered.	Outro: Questionnaire Questionnaire concerning artificial intelligence and its implementation in healthcare. GI patients and GI physicians will be provided with slightly different questionnaires.
Gastroenterology physicians GI physicians (both gastroenterologists and gastroenterology fellows), participating in a yearly gastroenterology and hepatology training day, will be asked for their participation in this study. Physician will be asked to complete a questionnaire concerning AI. No intervention will be administered.	Outro: Questionnaire Questionnaire concerning artificial intelligence and its implementation in healthcare. GI patients and GI physicians will be provided with slightly different questionnaires.

Grupo / Coorte

Intervenção / Tratamento

Gastroenterology patients

Patient receiving an endoscopic procedure because of regular care will be considered eligible for inclusion. Patients receive an endoscopic procedure in the context of the Dutch national screening program, because of gastrointestinal symptoms, or because of follow-up of previously diagnosed bowel diseases.

Patients will be asked to complete a questionnaire concerning AI. No intervention will be administered.

Outro: Questionnaire

Questionnaire concerning artificial intelligence and its implementation in healthcare. GI patients and GI physicians will be provided with slightly different questionnaires.

Gastroenterology physicians

GI physicians (both gastroenterologists and gastroenterology fellows), participating in a yearly gastroenterology and hepatology training day, will be asked for their participation in this study.

Physician will be asked to complete a questionnaire concerning AI. No intervention will be administered.

Outro: Questionnaire

Questionnaire concerning artificial intelligence and its implementation in healthcare. GI patients and GI physicians will be provided with slightly different questionnaires.

O que o estudo está medindo?

Medidas de resultados primários

Medida de resultado	Descrição da medida	Prazo
The knowledge on AI investigated by means of a questionnaire Prazo: 6 months	The knowledge on AI in healthcare among gastroenterology patients and physicians, investigated by means of a questionnaire.	6 months
The experience with AI investigated by means of a questionnaire Prazo: 6 months	The experience with AI (in healthcare) among gastroenterology patients and physicians, investigated by means of a questionnaire.	6 months
The opinion on AI investigated by means of a questionnaire Prazo: 6 months	The oninion on AI in healthcare among gastroenterology patients and physicians, investigated by means of a questionnaire.	6 months

Medidas de resultados secundários

Medida de resultado	Descrição da medida	Prazo
Willingness of physicians to use AI in (gastroenterology) healthcare Prazo: 6 months	The willingness to apply AI in (gastroenterology) healthcare among gastroenterology physicians.	6 months
Willingness to apply AI in (gastroenterology) healthcare Prazo: 6 months	The willingness of gastroenterology patients for their physicians to apply AI in (gastroenterology) healthcare.	6 months
Advantages and disadvantages of AI use in (gastroenterology) healthcare Prazo: 6 months	Important advantages and disadvantages of AI use in (gastroenterology) healthcare among gastroenterology patients and physicians.	6 months
Potential domains within gastroenterology and hepatology for AI use Prazo: 6 months	Potential domains within gastroenterology and hepatology for AI use indicated by GI physicians.	6 months
Mandatory infrastructure for AI use in healthcare Prazo: 6 months	The availability of technical facilities and infrastructures within endoscopy to implement and apply AI in Dutch hospitals.	6 months

Colaboradores e Investigadores

É aqui que você encontrará pessoas e organizações envolvidas com este estudo.

Patrocinador

Maastricht University Medical Center

Colaboradores

Catharina Ziekenhuis Eindhoven

Investigadores

Investigador principal: Ad Masclee, Prof Dr MD, Maastricht Universitair Medisch Centrum

Publicações e links úteis

A pessoa responsável por inserir informações sobre o estudo fornece voluntariamente essas publicações. Estes podem ser sobre qualquer coisa relacionada ao estudo.

Publicações Gerais

Datas de registro do estudo

Essas datas acompanham o progresso do registro do estudo e os envios de resumo dos resultados para ClinicalTrials.gov. Os registros do estudo e os resultados relatados são revisados pela National Library of Medicine (NLM) para garantir que atendam aos padrões específicos de controle de qualidade antes de serem publicados no site público.

Datas Principais do Estudo

Início do estudo (Real)

8 de abril de 2020

Conclusão Primária (Real)

12 de agosto de 2021

Conclusão do estudo (Real)

12 de agosto de 2021

Datas de inscrição no estudo

Enviado pela primeira vez

13 de janeiro de 2022

Enviado pela primeira vez que atendeu aos critérios de CQ

26 de janeiro de 2022

Primeira postagem (Real)

31 de janeiro de 2022

Atualizações de registro de estudo

Última Atualização Postada (Real)

18 de fevereiro de 2022

Última atualização enviada que atendeu aos critérios de controle de qualidade

3 de fevereiro de 2022

Última verificação

1 de fevereiro de 2022

Mais Informações

Termos relacionados a este estudo

Palavras-chave

Termos MeSH relevantes adicionais

Outros números de identificação do estudo

METC 2020-2281

Plano para dados de participantes individuais (IPD)

Planeja compartilhar dados de participantes individuais (IPD)?

SIM

Descrição do plano IPD

Data collected for the study, including individual participant data, will be made available upon request. This data includes deidentified participant data. Additional documents that will be made available are the study protocol, the statistical analysis plan, the questionnaires, and the informed consent forms. Data will be available following publication with no end date. Requests should be methodologically sound proposals with the purpose to achieve aims in the approved proposal. Researchers who request the data should direct the proposal to q.vanderzander@maastrichtuniversity.nl to gain access. Data requestors will need to sign a data access agreement after approval of a proposal.

Prazo de Compartilhamento de IPD

Data will be available following publication with no end date.

Critérios de acesso de compartilhamento IPD

Requests should be methodologically sound proposals with the purpose to achieve aims in the approved proposal. Data requestors will need to sign a data access agreement after approval of a proposal.

Tipo de informação de suporte de compartilhamento de IPD

PROTOCOLO DE ESTUDO
SEIVA
CIF

Informações sobre medicamentos e dispositivos, documentos de estudo

Estuda um medicamento regulamentado pela FDA dos EUA

Não

Estuda um produto de dispositivo regulamentado pela FDA dos EUA

Não

Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .

Questionnaire Study Concerning Artificial Intelligence